---
figid: PMC7981899__13045_2021_1060_Fig1_HTML
figlink: pmc/articles/PMC7981899/figure/Fig1/
number: F1
caption: Chemokines and their receptors’ roles in acute lymphoblastic leukemia. In
  osteoblastic niche, T-ALL cells are in direct, stable contact with vascular cells
  in the BM that produce CXCL12, while in vascular niche CXCL12 is secreted by several
  stromal cell types, especially CAR cells. Apart from the BM microenvironment, extramedullary
  organs such as the brain and spleen showed high expression of CCL19, which is involved
  in leukemic cells’ infiltration to such sites. CXCL12/CXCR4 triggers the activation
  of downstream kinases Src and ABL1 which are responsible for the phosphorylation
  of RhoGDI2, which released RhoA and RhoC, leading to subsequent cytoskeleton redistribution
  and assembly in the process of migration. CXCR4 could activate both ERK1/2 and PI3K/Akt
  pathways to promote the survival of leukemic blasts. In the homing of B cell progenitor
  ALL cells to the BM, CXCL12-mediated activation of p38MAPK was required and ZAP70
  kinase can control the expression of CXCR4 and CCR7 via ERK1/2, which is correlated
  with CNS infiltration during T-ALL. CXCR4 could also activate RAC1 to mediate migration
  and engraftment of B-ALL cells in the BM or testicles. In addition, CXCR4 can induce
  the proliferation of T-ALL cells via Myc. CXCL10/CXCR3 axis may increase survival
  rate of leukemic cells during treatment through stabilizing Bcl-2 and inhibiting
  caspase activation. CXCL10 has also been proved to promote migration of leukemic
  cells via MMP9. The expression of CCR5 and CCR7 is regulated by Notch-1. CCR5 regulate
  leukemic cell’s proliferation and anti-apoptosis through JAK/STAT3 pathway. CCL25/CCR9
  axis increase drug efflux-induced resistance by activating the binding of P-gp and
  ERM. It also facilitates the infiltration through RhoA-Rock-MLC and PI3K/AKT-RhoA
  pathway
pmcid: PMC7981899
papertitle: Targeting chemokines for acute lymphoblastic leukemia therapy.
reftext: Zixi Hong, et al. J Hematol Oncol. 2021;14:48.
pmc_ranked_result_index: '101104'
pathway_score: 0.9384637
filename: 13045_2021_1060_Fig1_HTML.jpg
figtitle: Chemokines and their receptors’ roles in acute lymphoblastic leukemia
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7981899__13045_2021_1060_Fig1_HTML.html
  '@type': Dataset
  description: Chemokines and their receptors’ roles in acute lymphoblastic leukemia.
    In osteoblastic niche, T-ALL cells are in direct, stable contact with vascular
    cells in the BM that produce CXCL12, while in vascular niche CXCL12 is secreted
    by several stromal cell types, especially CAR cells. Apart from the BM microenvironment,
    extramedullary organs such as the brain and spleen showed high expression of CCL19,
    which is involved in leukemic cells’ infiltration to such sites. CXCL12/CXCR4
    triggers the activation of downstream kinases Src and ABL1 which are responsible
    for the phosphorylation of RhoGDI2, which released RhoA and RhoC, leading to subsequent
    cytoskeleton redistribution and assembly in the process of migration. CXCR4 could
    activate both ERK1/2 and PI3K/Akt pathways to promote the survival of leukemic
    blasts. In the homing of B cell progenitor ALL cells to the BM, CXCL12-mediated
    activation of p38MAPK was required and ZAP70 kinase can control the expression
    of CXCR4 and CCR7 via ERK1/2, which is correlated with CNS infiltration during
    T-ALL. CXCR4 could also activate RAC1 to mediate migration and engraftment of
    B-ALL cells in the BM or testicles. In addition, CXCR4 can induce the proliferation
    of T-ALL cells via Myc. CXCL10/CXCR3 axis may increase survival rate of leukemic
    cells during treatment through stabilizing Bcl-2 and inhibiting caspase activation.
    CXCL10 has also been proved to promote migration of leukemic cells via MMP9. The
    expression of CCR5 and CCR7 is regulated by Notch-1. CCR5 regulate leukemic cell’s
    proliferation and anti-apoptosis through JAK/STAT3 pathway. CCL25/CCR9 axis increase
    drug efflux-induced resistance by activating the binding of P-gp and ERM. It also
    facilitates the infiltration through RhoA-Rock-MLC and PI3K/AKT-RhoA pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCL19
  - CXCL12
  - PECAM1
  - CCL25
  - CXCR3
  - CCR7
  - CCR9
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - HRAS
  - KRAS
  - NRAS
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - MAP2K3
  - MAP2K6
  - SRC
  - ABL1
  - MYC
  - ARAF
  - BRAF
  - RAF1
  - MMP9
  - NOTCH1
  - STAT3
  - AKT2
  - AKT3
  - AKT1
  - MAPK3
  - MAPK1
  - RHOA
  - ROCK2
  - ROCK1
  - RHOC
  - RAC1
  - CASP1
  - CASP2
  - CASP8
  - CASP9
  - CASP14
  - CASP12
  - CASP3
  - CASP4
  - CASP5
  - CASP6
  - CASP7
  - CASP10
  - ZAP70
  - MLC1
genes:
- word: CCL19
  symbol: CCL19
  source: hgnc_symbol
  hgnc_symbol: CCL19
  entrez: '6363'
- word: CXCL12
  symbol: CXCL12
  source: hgnc_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: CD31+
  symbol: CD31
  source: hgnc_alias_symbol
  hgnc_symbol: PECAM1
  entrez: '5175'
- word: CXCL12
  symbol: CXCL12
  source: hgnc_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: CCL19
  symbol: CCL19
  source: hgnc_symbol
  hgnc_symbol: CCL19
  entrez: '6363'
- word: CCL25
  symbol: CCL25
  source: hgnc_symbol
  hgnc_symbol: CCL25
  entrez: '6370'
- word: CXCR3
  symbol: CXCR3
  source: hgnc_symbol
  hgnc_symbol: CXCR3
  entrez: '2833'
- word: CCR7
  symbol: CCR7
  source: hgnc_symbol
  hgnc_symbol: CCR7
  entrez: '1236'
- word: CCR9
  symbol: CCR9
  source: hgnc_symbol
  hgnc_symbol: CCR9
  entrez: '10803'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MKK3/6
  symbol: MKK3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: MKK3/6
  symbol: MKK6
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K6
  entrez: '5608'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: ABL1
  symbol: ABL1
  source: hgnc_symbol
  hgnc_symbol: ABL1
  entrez: '25'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MMP9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: Notch-1
  symbol: NOTCH1
  source: hgnc_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Notch-1
  symbol: NOTCH1
  source: hgnc_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Rock
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK2
  entrez: '9475'
- word: Rock
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK1
  entrez: '6093'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RhoA/RhoC
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: RhoA/RhoC
  symbol: RhoC
  source: hgnc_alias_symbol
  hgnc_symbol: RHOC
  entrez: '389'
- word: RAC1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: ZAP70
  symbol: ZAP70
  source: hgnc_symbol
  hgnc_symbol: ZAP70
  entrez: '7535'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: MLC
  symbol: MLC
  source: hgnc_alias_symbol
  hgnc_symbol: MLC1
  entrez: '23209'
chemicals: []
diseases: []
figid_alias: PMC7981899__F1
redirect_from: /figures/PMC7981899__F1
figtype: Figure
---
